Advertisement

Topics

SCYNEXIS, Inc. Company Profile

19:19 EST 23rd November 2017 | BioPortfolio

SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas.In the discovery phase SCYNEXIS offers its services primarily in the form of integrated research teams consisting of medicinal chemists, computational chemists, analytical chemists and bioanalytical scientists to work on a collaborative basis with our customers on projects from hit to candidate selection. SCYNEXIS project leaders of these multi-disciplinary teams are knowledgeable scientists with years of industry experience. They coordinate and communicate key activities and drive resources to achieve success. SCYNEXIS research teams use powerful, proprietary technologies such as the HEOS® Software Suite, MEDCHEM-FACTORY™ and KIT™ Kinase Inhibitor Technology to deliver maximum results to our customers.

Location

Post Office Box 12878
Research Triangle Park
North Carolina
27709-2878
United States of America

Contact

Phone: (919) 544-8600
Fax: (919) 544-8697
Email: Market.Development@scynexis.com


News Articles [14 Associated News Articles listed on BioPortfolio]

Analyzing SCYNEXIS

SCYNEXIS and Impax Laboratories are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, v...

Financial Analysis: SCYNEXIS

SCYNEXIS and Impax Laboratories are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, va...

SCYNEXIS Appoints Scott Sukenick as General Counsel

"Scott brings invaluable legal and strategic expertise to SCYNEXIS as we continue to advance our lead asset, SCY-078, through clinical development," said Marco Taglietti, Read more...

Scynexis Q2 - Steady As She Goes

Scynexis: A $2 'Busted IPO' And Lottery Ticket?

Management tracks: Scynexis, Context

SCYNEXIS to Present Data on Lead Antifungal Candidate SCY-078 at IDWeek 2017

Additional SCY-078 Posters to be Presented at 8th Trends in Medical Mycology Pre-clinical data further highlight SCY-078’s broad spectrum of activity and differentiated attributes JERSEY CITY,...

SCYNEXIS Presents New Data Further Supporting SCY-078 as a Potential Treatment for Aspergillus and Candida Infections at IDWeek 2017

JERSEY CITY, N.J., Oct. 05, 2017 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-thr...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

SCYNEXIS, Inc.

SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences indu...

More Information about "SCYNEXIS, Inc." on BioPortfolio

We have published hundreds of SCYNEXIS, Inc. news stories on BioPortfolio along with dozens of SCYNEXIS, Inc. Clinical Trials and PubMed Articles about SCYNEXIS, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SCYNEXIS, Inc. Companies in our database. You can also find out about relevant SCYNEXIS, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record